Lempo Therapeutics

Lempo Therapeutics Overview

Lempo Therapeutics is a preclinical biotech company that uses gene editing to modify the immune system for attenuating severe chronic diseases. The companys novel, patented treatment uses an ex vivo stem cell gene-editing technique to minimize the collateral damage caused by immune system activity, thereby significantly mitigating disease progression. Lempos initial focus is on treating pulmonary arterial hypertension (PAH), a rare and devastating cardiovascular disease that leads to heart failure and death if left untreated. The companys concept has already been proven effective in animal models for the treatment of Alzheimers disease, multiple sclerosis, cardiovascular diseases, and more.

Latest News

No news articles.

Funding

Team Members

3

Employees: 1-10

Web & Social Links

Locations

Sheshet HaYamim Street 86, Binyamina-Giv'at Ada, Israel

Photos & Videos

1 item(s)

Lempo Therapeutics Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info